These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23763006)

  • 1. Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment.
    Wiser A; Shehata F; Holzer H; Hyman JH; Shalom-Paz E; Son WY; Tulandi T
    J Reprod Med; 2013; 58(5-6):219-23. PubMed ID: 23763006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of basal serum luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio on outcomes of in vitro fertilization-embryo transfer in patients with polycystic ovarian syndrome].
    Geng X; Ou X; Liao Y; Tan W; Wang S; Quan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):857-60. PubMed ID: 23803197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
    Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.
    Ganor-Paz Y; Friedler-Mashiach Y; Ghetler Y; Hershko-Klement A; Berkovitz A; Gonen O; Shulman A; Wiser A
    J Endocrinol Invest; 2016 Jul; 39(7):799-803. PubMed ID: 26797707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
    He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization].
    Ellenbogen A; Atamny R; Fainaru O; Meidan E; Rotfarb N; Michaeli M
    Harefuah; 2011 Nov; 150(11):833-6, 876. PubMed ID: 22428202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
    Jin J; Ruan X; Hua L; Tian X; Li Y; Wang L; Mueck AO
    Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?
    Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
    Gynecol Endocrinol; 2012 Jun; 28(6):422-4. PubMed ID: 22578028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
    Liu KE; Greenblatt EM
    Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
    Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.
    Cho LW; Jayagopal V; Kilpatrick ES; Holding S; Atkin SL
    Ann Clin Biochem; 2006 May; 43(Pt 3):217-9. PubMed ID: 16704758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of luteinizing hormone and follicle stimulating hormone on the developmental competence of porcine preantral follicle oocytes grown in vitro.
    Wu J; Xu B; Wang W
    J Assist Reprod Genet; 2007 Sep; 24(9):419-24. PubMed ID: 17636438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.